Family Firm Inc. Lowers Holdings in Encompass Health Corporation $EHC

Family Firm Inc. reduced its stake in shares of Encompass Health Corporation (NYSE:EHC) by 38.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,077 shares of the company’s stock after selling 12,357 shares during the period. Family Firm Inc.’s holdings in Encompass Health were worth $2,462,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. WPG Advisers LLC purchased a new position in shares of Encompass Health in the 1st quarter valued at $27,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Encompass Health by 749.0% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock valued at $42,000 after acquiring an additional 367 shares in the last quarter. Parkside Financial Bank & Trust raised its stake in shares of Encompass Health by 179.5% during the second quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock valued at $59,000 after purchasing an additional 307 shares during the period. Park Place Capital Corp acquired a new position in shares of Encompass Health during the second quarter worth $72,000. Finally, Caitong International Asset Management Co. Ltd boosted its stake in shares of Encompass Health by 19.0% in the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock valued at $73,000 after purchasing an additional 115 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Trading Down 0.4%

Encompass Health stock opened at $114.32 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The firm’s 50-day moving average is $122.88 and its 200-day moving average is $119.68. Encompass Health Corporation has a 1 year low of $87.85 and a 1 year high of $127.99. The company has a market cap of $11.50 billion, a P/E ratio of 21.61, a PEG ratio of 2.20 and a beta of 0.91.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. The business had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, equities analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be given a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Friday, January 2nd. Encompass Health’s payout ratio is 14.37%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on EHC. Bank of America upped their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, September 10th. KeyCorp increased their price target on Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a report on Tuesday, September 16th. Zacks Research upgraded Encompass Health from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 21st. Truist Financial increased their target price on Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research note on Thursday, August 14th. Finally, Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Three equities research analysts have rated the stock with a Strong Buy rating and eight have given a Buy rating to the stock. According to data from MarketBeat.com, Encompass Health has an average rating of “Buy” and an average target price of $142.86.

Insider Buying and Selling at Encompass Health

In other news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the transaction, the executive vice president directly owned 18,846 shares in the company, valued at $2,329,177.14. This trade represents a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 2.00% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.